This study is currently not recruiting participants.

MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD) (MOBILE CA)

Investigation of a Device for Critical Limb Ischemia

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to continue to evaluate the performance of the MarrowStim PAD Kit to treat subjects with critical limb ischemia (CLI) caused by severe PAD.

Detailed description of study

The purpose of this study is to continue to evaluate the performance of the MarrowStim PAD Kit to treat subjects with critical limb ischemia (CLI) caused by severe PAD.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: ischemia
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate a device for individuals with critical limb ischemia (CLI), a severe condition caused by peripheral artery disease (PAD). This condition affects blood flow to the limbs, leading to pain and potential tissue damage.

Participants in the study will undergo procedures to assess the effectiveness of the investigational device. Critical limb ischemia is a serious condition that requires careful monitoring and treatment.

  • Who can participate: Adults aged 18 and older with a diagnosis of critical limb ischemia are eligible. Key eligibility factors include a history of peripheral artery disease and current symptoms indicating severe blood flow restriction.
  • Study details: Participants will undergo evaluations including imaging and functional tests to assess the investigational device's effectiveness for treating CLI.
Updated on 19 Feb 2024. Study ID: 1509062795

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team